Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | NADPH | HCID 5884 | — |
| Reactant | Udp-glucuronic acid | HCID 17473 | — |
| Reactant | Magnesium Chloride | HCID 5360315 | — |
| Reactant | HCID 178513073 | HCID 178513073 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | HCID 178513078 | HCID 178513078 | — |
Reaction Steps
4.8 mg of N-(1-quinolin-4-yl-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-guanidine were dissolved using 150 ml of an aqueous solution containing 381 mg MgCl2, 1.3 mM NADPH (Dihydronicotinamide adenine dinucleotide phosphate, Calbiochem product number: 481973; Shen, A. L., et al. 1989. J. Biol. Chem. 264, 7584; Yamano, S., et al. 1989. Mol. Pharmacol. 36, 83.), 300 mg of human S9 fraction and 2.5 mM UDPGA (Uridine 5′-diphosphoglucuronic acid trisodium salt, Sigma catalog number U6751). The mixture was incubated for 120 minutes at 37° C. Then, 40 ml of acetonitrile were added, proteins centrifuged and decanted. This solution was concentrated to 100 ml and chromatographed using the system described below. The solvents were removed under reduced pressure to yield 0.9 mg of N-[1-(2-hydroxy-quinolin-4-yl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-guanidine as an amorphous solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07230007B2 |
|---|
| Source dataset | uspto-grants-2007_06 |
|---|
| ORD ID | ord-b68fa4f6388441388165def11d5c1e30 |
|---|
| Source note | uspto-grants-2007_06 |
|---|